Last Updated: August 9, 2026

HEPARIN SODIUM PRESERVATIVE FREE Drug Patent Profile

Name: HEPARIN SODIUM PRESERVATIVE FREE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Heparin Sodium Preservative Free patents expire, and what generic alternatives are available?

Heparin Sodium Preservative Free is a drug marketed by Dr Reddys, Emerge Bioscience, Fresenius Kabi Usa, Hospira, Pfizer, Pharma Serve Ny, Sagent Pharms, and Shenzhen Techdow. and is included in nine NDAs.

The generic ingredient in HEPARIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Heparin Sodium Preservative Free

A generic version of HEPARIN SODIUM PRESERVATIVE FREE was approved as heparin sodium by HOSPIRA on April 28^th, 1983.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for HEPARIN SODIUM PRESERVATIVE FREE?
What are the global sales for HEPARIN SODIUM PRESERVATIVE FREE?
What is Average Wholesale Price for HEPARIN SODIUM PRESERVATIVE FREE?

Summary for HEPARIN SODIUM PRESERVATIVE FREE

US Patents:	0
Applicants:	8
NDAs:	9
Finished Product Suppliers / Packagers:	11
Clinical Trials:	4
DailyMed Link:	HEPARIN SODIUM PRESERVATIVE FREE at DailyMed

Drug patent expirations by year for HEPARIN SODIUM PRESERVATIVE FREE

Recent Clinical Trials for HEPARIN SODIUM PRESERVATIVE FREE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Joshua Sharp	Early Phase 1
Ain Shams University	Phase 4
PPD	Phase 3

See all HEPARIN SODIUM PRESERVATIVE FREE clinical trials

Pharmacology for HEPARIN SODIUM PRESERVATIVE FREE

Drug Class	Anti-coagulant Unfractionated Heparin

US Patents and Regulatory Information for HEPARIN SODIUM PRESERVATIVE FREE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	089464-001	Jun 3, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hospira	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	089522-001	May 4, 1987	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fresenius Kabi Usa	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	017029-019	Nov 22, 2010	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pfizer	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	201370-004	Jul 21, 2011		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Emerge Bioscience	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	212060-001	Apr 2, 2020	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Fresenius Kabi Usa	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	017029-010	Apr 28, 1986	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.